| INTRODUCTION
The detection of early lung carcinomas has been facilitated in Japan by chest radiography imaging being commonly performed in annual health checkups and chest computed tomography (CT) now being widely used in routine investigations. Furthermore, recent developments in imaging modalities and the widespread use of low-dose helical CT for the screening of lung cancer have led to an increase in the detection rate of pulmonary peripheral lesions. 1 Noguchi et al. previously reported that bronchioloalveolar carcinoma (BAC), which is regarded as adenocarcinoma in situ (AIS), has a favorable prognosis Jun Matsubayashi and Shinji Miyake share joint first authorship as they contributed equally to this work.
with a 5-year survival rate of 100%, while adenocarcinoma with an invasive component has a poor prognosis despite the small tumor size. 2 Furthermore, according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification of lung adenocarcinomas, patients with AIS and minimally invasive adenocarcinoma (MIA) show a more favorable course than those with invasive adenocarcinoma (IAD). 3 MIA is defined as a small (≤3 cm in diameter), solitary adenocarcinoma with a predominantly lepidic pattern and ≤5 mm invasion in the greatest dimension. MIA is excluded if the tumor invades the lymphatics, blood vessels, air spaces, or pleura; contains tumor necrosis;
or spreads through the air spaces. 3 In 2015, the 4th edition of WHO classification of lung adenocarcinomas, which was based on the IASL-C/ATS/ERS classification, was published, emphasizing the significance of histological subtypes for assessing the prognosis of patients. This has been validated in independent cohorts. 4, 5 Previous studies have examined the relationship between the IASLC/ATS/ERS classification of histological subtypes and radiological features in lung adenocarcinomas. [6] [7] [8] We reported that high-resolution CT (HRCT) findings correlated with the IASLC/ATS/ERS classification and were useful for evaluating the histological features of tumors. IA lung adenocarcinoma than the whole tumor size. 9 However, difficulties remain with accurately identifying the foci of invasion in lung adenocarcinomas clinically due to the challenges associated with distinguishing central scars from the foci of invasion on CT. 8 Furthermore, while active fibroblasts and a papillary growth pattern are histological hallmarks of invasion in lung adenocarcinomas, 2, 10 it is difficult to detect these findings in small biopsy or cytology specimens.
We investigated the cytological differences between IAD and noninvasive or minimally invasive adenocarcinoma (NMIAD) diagnosed in Japanese patients based on the new WHO classification using CT-guided needle aspiration cytology specimens of peripheral pulmonary lesions ≤3 cm in diameter to investigate whether or not differences in the cytological characteristics between IAD and NMIAD may contribute to the differential diagnosis. Therefore, the objective of the present study was to identify more readily discernible differences in the cytological characteristics of IAD and NMIAD.
| MATERIALS AND METHODS

| Patient selection
A total of 1752 consecutive patients underwent pulmonary resection for primary lung cancer between January 1997 and December 2008 at Tokyo Medical University Hospital. Among these patients, 70 were pathologically proven to have primary peripheral lung adenocarcinomas ≤3 cm in diameter that showed pure ground-glass opacity (GGO) or partly solid nodules on preoperative CT-guided fine-needle aspiration cytology due to the difficulty of a transbronchial approach. Any patients with pure solid nodules on CT were excluded from this study, as were patients with synchronous multiple adenocarcinomas.
| Survival analyses
Data collection and analyses were approved and the need to obtain written informed consent from each patient was waived by the Institutional Review Board of Tokyo Medical University. The overall survival (OS) and recurrence-free survival (RFS) were estimated using the Kaplan-Meier method, and differences in the survival rates were determined using a Log-rank analysis (Mantel Cox method). The OS was defined as the time elapsed from the date of pulmonary resection to the date of death from any cause. Among patients in our series, the RFS was defined as the interval from the date of pulmonary resection to the date of recurrence, lung cancer-related death, or the last follow-up. The last follow-up observation was censored if the patient was alive or lost to follow-up.
A univariate analysis was conducted among the different groups.
Categorical variables were analyzed using the chi-squared test. Differences between two groups were tested using the Mann-Whitney U test. All P-values were two-sided, and P-values of <0.05 were considered to indicate a significant difference. All statistical calculations were performed using the StatView software program for Windows, version 5.0 (SAS Institute Inc, Cary, North Carolina).
| Histological and cytological evaluations
All resected specimens were fixed in formalin and embedded in paraf- The significance of differences between a score of 0 or 1 and a score of 2 was determined using the chi-squared test. All P values were two-sided, and P values of <0.05 were considered to indicate a significant difference. All statistical analyses were performed using the Statview software program (SAS Institute Inc).
3 | RESULTS Figure 1A ). No significant differences were observed in the OS between patients with AIS and papillary adenocarcinoma tumors, between those with MIA and papillary adenocarcinoma tumors, between those with lepidic adenocarcinoma and papillary adenocarcinoma tumors, or between patients with AIS + MIA and lepidic adenocarcinoma + papillary adenocarcinoma tumors (P = 0.192, P = 0.431, P = 0.596, and P = 0.298, respectively; Table 2 , Figure 1A ). Furthermore, AIS, MIA, lepidic adenocarcinoma, and AIS + MIA had a 100% 5-year RFS, while papillary adenocarcinoma and lepidic adenocarcinoma + papillary adenocarcinoma had a 76.2% and 82.8% 5-year RFS, respectively (Table 3 , Figure 1B ). Significant differences were observed in the RFS between patients with MIA and papillary adenocarcinoma tumors and between those with AIS + MIA and lepidic adenocarcinoma + papillary adenocarcinoma tumors (P = 0.002 and P = 0.003, respectively), while no significant differences were found in the RFS between patients with AIS and papillary adenocarcinoma tumors or between those with lepidic and papillary adenocarcinoma tumors (P = 0.101 and P = 0.106, respectively; Table 3 , Figure 1B ).
| Patient characteristics and the survival analysis
As a significant difference was observed in the RFS between patients with AIS + MIA and lepidic adenocarcinoma + papillary adenocarcinoma tumors, we evaluated both groups cytologically.
| The cytological analysis
The numbers of tumor cells were 39.8 ± 28.7 in the NMIAD group and 60.3 ± 40.5 in the IAD group (P = 0.0017; Figure 2A ). The numbers of stromal clusters were 11.8 ± 11.5 in the NMIAD group and 13.3 ± 11.2 in the IAD group (P = 0.59; Figure 2B ).
A univariate analysis revealed significant differences between the groups in the rates of large tumor cell clusters (P = 0.0106), 3D tumor cell clusters (P = 0.0017), and irregular nuclear contours (P = 0.0007; Figure 3A ,C). However, no significant differences were found in the fre- In six aspirates of these cases, additional features, such as pronounced nuclear crowding and overlapping, variation in nuclear size, and an increased number of pleomorphic cells, interfered with the FNAB diagnosis of BAC. Nine FNABs with a diagnosis of BAC were found histologically to have adenocarcinoma with a focal BAC growth pattern.
For small-sized peripheral lung adenocarcinoma, it is especially difficult to obtain a preoperative diagnosis. 15, 16 A CT-guided needle biopsy (CTNB) was first reported in 1976 17 and has since become a widely used diagnostic tool for the management of patients with suspected lung cancer. CTNBs are a relatively accurate method of diagnosing peripheral pulmonary lesions. [18] [19] [20] [21] In the present study, all cases evaluated were obtained using a CTNB because of their small size and peripheral location. Therefore, all of the cytology specimens were evaluated under the same conditions, morphologically. Furthermore, the IAD and NMIAD groups evaluated in the present study contained 31 and 39 cases, respectively, both of which are greater than in previous cytological studies of small lung adenocarcinomas.
To our knowledge, this is the first report of the cytological differences between IAD and NMIAD, which had pure GGO or partly solid nodules on preoperative CT in small peripheral pulmonary lesions, with a focus on invasion in early lung adenocarcinoma. Patients with pure solid nodules on CT were excluded from this study because in general, tumors in patients with purely solid nodules on preoperative CT histologically have much more prominent nuclear atypia and/or structural atypia than those in patients with pure GGO or partly solid nodules.
Although there were some cases with acinar, solid, micropapillary, or mucinous adenocarcinoma components, there were no acinar, solid, micropapillary, or mucinous-predominant adenocarcinoma cases in the IAD group in the present study. The reason why no mucinous adenocarcinoma cases were observed may have been because the patients in our study were all Japanese and therefore included many cases of adenocarcinoma with EGFR mutations. The findings from the present study suggest that several cytological parameters-namely irregular nuclear contours, large tumor cell clusters, and 3D clusters-may be useful for distinguishing IAD from NMIAD. A multivariate analysis
showed that the frequency of irregular nuclear contours was significantly higher in the IAD group than in the NMIAD group. Furthermore, the number of tumor cells was higher in the IAD group than in the NMIAD group, whereas no significant differences were observed in the number of stromal clusters between the two groups. These cytological characteristics, which were significantly higher or more prominent in the IAD group than in the NMIAD group, appear to support peripheral pulmonary lesions featuring pure GGO or partly solid nodules being IAD pathologically.
Adenocarcinoma is the most common histological subtype of lung cancer in Japan; it accounts for approximately 70% of all surgically resected lung cancers, and most cases occur as pulmonary peripheral lesions. 22 Patients with GGO-dominant small lung adenocarcinomas were previously reported to have a favorable prognosis. 23 Limited resection of the lung for early-stage lung cancers has recently been advocated from a clinical standpoint for the preservation of the lung function. 24 Therefore, GGO-dominant peripheral lung lesions may be candidates for limited surgical resection. 25 However, there are currently no established criteria for the indication of limited resection.
The new WHO classification clearly emphasizes the significance of the histological subtype for determining the prognosis of patients, and this has been validated in independent cohorts. Under the new classification system, AIS is defined as a preinvasive lesion, while MIA is in a new, separate category; both are distinguished from IAD because AIS and MIA have 100% disease-free survival and RFS
rates if the tumor is completely resected. 4, 26 We also revealed in the present study that AIS and MIA had a more favorable prognosis Furthermore, it is not possible to diagnose AIS or MIA using biopsy specimens alone, as central scars cannot be distinguished from the foci of invasion in lung cancer using only preoperative biopsy specimens. 14 In the present study, no significant differences were observed in the number of stroma between the IAD and NMIAD groups. This result indicates that it is difficult to distinguish the foci of invasion in
IADs from the scars in NMIAD.
Therefore, in addition to the chest CT and PET findings, the cytological characteristics of irregular nuclear contours, large tumor cell clusters, and 3D tumor cell clusters may play a role in making more accurate preoperative judgment of IAD.
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